Next Quarterly Earnings
Thursday, July 30, 2026
CW 31
After-Hours
In 25 days
Myriad Genetics is a leader in precision medicine, developing and marketing advanced genetic tests. These tests aid in the diagnosis, prognosis, and therapeutic decision-making for cancer and hereditary diseases. The company enhances patient care through innovative diagnostics, empowering healthcare providers with critical genetic insights for better outcomes.